Ras protein-specific guanine nucleotide-releasing factor 2 (RASGRF2)

Ras protein-specific guanine nucleotide-releasing factor 2 (RASGRF2) is a **calcium-regulated guanine nucleotide exchange factor (GEF)** that activates Ras and Rac family GTPases by promoting the exchange of GDP for GTP. RASGRF2 is critically involved in the regulation of intracellular signal transduction, mediating the conversion of calcium signals from NMDA receptors into Ras/Rac activation and downstream MAPK/ERK signaling. This protein is highly expressed in the brain, particularly in regions associated with learning, memory, and reward processing. Functionally, RASGRF2 is required for certain forms of synaptic plasticity, including NMDA receptor-dependent long-term potentiation (LTP), and it coordinates cytoskeletal remodeling at excitatory synapses via Rac1. RASGRF2 also modulates mesolimbic dopamine neuron activity, linking it to behavioral responses to substances such as alcohol, and genetic variation in RASGRF2 is associated with altered addiction risk in humans. No approved drugs directly target RASGRF2, but it is mechanistically upstream of pathways of therapeutic interest (e.g., MAPK/ERK)[1][2][3][4].

Other names

Ras-specific guanine nucleotide-releasing factor 2Ras-GRF2GRF2ras guanine nucleotide exchange factor 2RASGRF2ras guanine nucleotide-releasing factor 2

Drugs targeting this molecule would likely act by modulating its GDP/GTP exchange activity or its regulation of calcium/calmodulin-dependent Ras/Rac signaling pathways